Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway-Reference-Cited by-同舟云学术

Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway

Published:2013-09-15 Issue:18 Volume:12 Page:3109-3124
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

COROMINAS-FAJA BRUNA,CUFÍ SÍLVIA,Oliveras-Ferraros Cristina,CUYÀS ELISABET,López-Bonet Eugeni,LUPU RUTH,ALARCÓN TOMÁS,Vellon Luciano,MANUEL IGLESIAS JUAN,LEIS OLATZ,Martin Angel,Vazquez-Martin Alejandro,Menendez Javier A.

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/cc.26173

Reference100 articles.

1. Cancer stem cells: an old idea--a paradigm shift;Wicha;Cancer Res,2006

2. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy;Kakarala;J Clin Oncol,2008

3. Mammary stem cells, self-renewal pathways, and carcinogenesis;Liu;Breast Cancer Res,2005

4. The origins and implications of intratumor heterogeneity;Michor;Cancer Prev Res (Phila),2010

5. Cancer stem cells: impact, heterogeneity, and uncertainty;Magee;Cancer Cell,2012

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the Potential of Induced Pluripotent Stem Cells in Revolutionizing Cancer Therapy;Current Stem Cell Research & Therapy;2024-04-15

2. Role of hydroxymethylglutharyl-coenzyme A reductase in the induction of stem-like states in breast cancer;Journal of Cancer Research and Clinical Oncology;2024-02-28

3. Interconversion of Cancer Cells and Induced Pluripotent Stem Cells;Cells;2024-01-10

4. UBE2T mediates the stemness properties of breast cancer cells through the mTOR signaling pathway;BIOCELL;2024

5. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease;Signal Transduction and Targeted Therapy;2023-10-02